Boule Diagnostics Management
Management criteria checks 4/4
Boule Diagnostics' CEO is Jesper Soderqvist, appointed in May 2020, has a tenure of 2.42 years. total yearly compensation is SEK3.94M, comprised of 69.3% salary and 30.7% bonuses, including company stock and options. directly owns 0.095% of the company’s shares, worth SEK296.00K. The average tenure of the management team and the board of directors is 2.5 years and 6.8 years respectively.
Key information
Jesper Soderqvist
Chief executive officer
SEK 3.9m
Total compensation
| CEO salary percentage | 69.3% |
| CEO tenure | 2.4yrs |
| CEO ownership | 0.1% |
| Management average tenure | 2.5yrs |
| Board average tenure | 6.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | SEK 32m |
| Mar 31 2022 | n/a | n/a | SEK 28m |
| Dec 31 2021 | SEK 4m | SEK 3m | SEK 23m |
| Sep 30 2021 | n/a | n/a | -SEK 27m |
| Jun 30 2021 | n/a | n/a | -SEK 13m |
| Mar 31 2021 | n/a | n/a | -SEK 55m |
| Dec 31 2020 | SEK 3m | SEK 2m | -SEK 48m |
Compensation vs Market: Jesper's total compensation ($USD359.45K) is about average for companies of similar size in the UK market ($USD348.41K).
Compensation vs Earnings: Jesper's compensation has been consistent with company performance over the past year.
CEO
Jesper Soderqvist (56 yo)
2.4yrs
Tenure
SEK 3,944,000
Compensation
Mr. Jesper Söderqvist, Ph D., served as Director at Arcoma AB since June 2020 until May 2022 and Board Member and Chief Executive Officer of Dekatria AB. He served as Chief Executive Officer of Arcoma AB u...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.4yrs | SEK 3.94m | 0.095% SEK 296.0k | |
| Senior VP & CFO | less than a year | no data | no data | |
| Chief Technology Officer | 2.1yrs | no data | 0.0041% SEK 12.8k | |
| Senior Vice President of Marketing | less than a year | no data | no data | |
| Senior Vice President of People & Culture | no data | no data | no data | |
| Head of Marketing | 18.8yrs | no data | no data | |
| Head of Development - Reagents & Consumables | 30.8yrs | no data | no data | |
| Head of Development - Instruments & Systems | 15.8yrs | no data | no data | |
| Senior Vice President of Commercial Operations | 4.6yrs | no data | 0.010% SEK 32.0k | |
| Senior Vice President of Instrument Production | 2.7yrs | no data | no data | |
| Senior Vice President of Production of Consumables | no data | no data | no data | |
| Senior Vice President of Quality & Regularity Affairs | 1.2yrs | no data | no data |
2.5yrs
Average Tenure
59yo
Average Age
Experienced Management: BOULS's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman of the Board | 1.4yrs | no data | 0.010% SEK 32.0k | |
| Independent Director | 6.8yrs | SEK 235.00k | 0.055% SEK 172.4k | |
| Director | 8.8yrs | SEK 235.00k | 10.07% SEK 31.3m | |
| Independent Director | 7.8yrs | SEK 235.00k | 0.055% SEK 170.4k | |
| Independent Director | 1.8yrs | no data | no data |
6.8yrs
Average Tenure
63yo
Average Age
Experienced Board: BOULS's board of directors are considered experienced (6.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/10/29 06:45 |
| End of Day Share Price | 2022/08/01 00:00 |
| Earnings | 2022/06/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Boule Diagnostics AB (publ) is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jakob Lembke | ABG Sundal Collier Sponsored |
| null null | ABG Sundal Collier Sponsored |
| Christian Lee | Pareto Securities |